PE20020083A1 - DERIVADOS DE DIPIRIDO[[3,2-b:2',3'-e][1,4] DIAZEPIN-6-ONA COMO INHIBIDORES DE LA TRANSCRIPTASA INVERSA - Google Patents
DERIVADOS DE DIPIRIDO[[3,2-b:2',3'-e][1,4] DIAZEPIN-6-ONA COMO INHIBIDORES DE LA TRANSCRIPTASA INVERSAInfo
- Publication number
- PE20020083A1 PE20020083A1 PE2001000560A PE2001000560A PE20020083A1 PE 20020083 A1 PE20020083 A1 PE 20020083A1 PE 2001000560 A PE2001000560 A PE 2001000560A PE 2001000560 A PE2001000560 A PE 2001000560A PE 20020083 A1 PE20020083 A1 PE 20020083A1
- Authority
- PE
- Peru
- Prior art keywords
- methyl
- diazepin
- ona
- ethyl
- reverse transcriptase
- Prior art date
Links
- 102100034343 Integrase Human genes 0.000 title 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 5
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 4
- -1 ISOPROPYL Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical group [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 abstract 1
- XIPUIGPNIDKXJU-UHFFFAOYSA-N [CH]1CC1 Chemical group [CH]1CC1 XIPUIGPNIDKXJU-UHFFFAOYSA-N 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE DIPIRIDO[[3,2-b:2',3'-e][1,4] DIAZEPIN-6-ONA DE FORMULA I DONDE R2 ES H, F, Cl, ALQUILO C1-C4, CICLOALQUILO C3-C4, CF3; R4 ES H, METILO; R5 ES H, METILO, ETILO CON LA CONDICION DE QUE R4 Y R5 NO SEAN AMBOS METILO Y SI R4 ES METILO, ENTONCES R5 NO PUEDE SER ETILO; R11 ES METILO, ETILO, CICLOPROPILO, PROPILO, ISOPROPILO, CICLOBUTILO; Q ES EL GRUPO a, GRUPO b, ENTRE OTROS.UN COMPUESTO PREFERIDO ES 5,11-DIHIDRO-11-ETIL-5-METIL-8-{2-(4-QUINOLINILOXI)ETIL}-6H-DIPIRIDO[3,2-b:2',3'-e][1,4]DIAZEPIN-6-ONA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS DE FORMULA I SON INHIBIDORES DE LA TRANSCRIPTASA INVERSA Y SON UTILES PARA EL TRATAMIENTO DE INFECCION POR VIH
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21232900P | 2000-06-16 | 2000-06-16 | |
| US25663800P | 2000-12-18 | 2000-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020083A1 true PE20020083A1 (es) | 2002-02-28 |
Family
ID=26907019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000560A PE20020083A1 (es) | 2000-06-16 | 2001-06-14 | DERIVADOS DE DIPIRIDO[[3,2-b:2',3'-e][1,4] DIAZEPIN-6-ONA COMO INHIBIDORES DE LA TRANSCRIPTASA INVERSA |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6420359B1 (es) |
| EP (1) | EP1294720B1 (es) |
| JP (1) | JP3923894B2 (es) |
| KR (1) | KR20030017540A (es) |
| CN (1) | CN1178939C (es) |
| AR (1) | AR028958A1 (es) |
| AT (1) | ATE322492T1 (es) |
| AU (2) | AU2001270370B2 (es) |
| BG (1) | BG107348A (es) |
| BR (1) | BR0102377A (es) |
| CA (1) | CA2411766C (es) |
| CZ (1) | CZ20024114A3 (es) |
| DE (1) | DE60118560T2 (es) |
| DK (1) | DK1294720T3 (es) |
| EA (1) | EA005598B1 (es) |
| EE (1) | EE200200690A (es) |
| ES (1) | ES2261433T3 (es) |
| HR (1) | HRP20021003A2 (es) |
| HU (1) | HUP0301105A2 (es) |
| IL (1) | IL152819A0 (es) |
| MX (1) | MXPA02012205A (es) |
| MY (1) | MY130375A (es) |
| NO (1) | NO323830B1 (es) |
| NZ (1) | NZ523549A (es) |
| PE (1) | PE20020083A1 (es) |
| PL (1) | PL360370A1 (es) |
| PT (1) | PT1294720E (es) |
| SA (1) | SA01220202B1 (es) |
| SK (1) | SK17722002A3 (es) |
| TW (1) | TWI270547B (es) |
| UA (1) | UA74834C2 (es) |
| UY (1) | UY26767A1 (es) |
| WO (1) | WO2001096338A1 (es) |
| YU (1) | YU94202A (es) |
| ZA (1) | ZA200209807B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716836B2 (en) | 2001-03-22 | 2004-04-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6673791B2 (en) * | 2001-07-30 | 2004-01-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6706706B2 (en) * | 2002-03-27 | 2004-03-16 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| US6806265B2 (en) * | 2002-05-16 | 2004-10-19 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| US6759533B2 (en) * | 2002-06-28 | 2004-07-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors |
| US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| UA81003C2 (en) * | 2002-12-16 | 2007-11-26 | Boehringer Ingelheim Int | Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450 |
| WO2004087140A1 (en) * | 2003-03-27 | 2004-10-14 | Boehringer Ingelheim International Gmbh | Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound |
| US7309700B2 (en) * | 2004-04-02 | 2007-12-18 | Boehringer Ingelheim International Gmbh | Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one |
| US20060025480A1 (en) | 2004-08-02 | 2006-02-02 | Boehringer Ingelheim International Gmbh | Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors |
| US7151174B2 (en) | 2004-11-05 | 2006-12-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor |
| WO2007067844A1 (en) * | 2005-12-05 | 2007-06-14 | Boehringer Ingelheim International Gmbh | Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
| EP2085390A1 (en) | 2008-01-31 | 2009-08-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| EA201101397A1 (ru) * | 2009-04-09 | 2012-05-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Ингибиторы репликации вируса иммунодефицита человека |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| US5705499A (en) * | 1995-10-06 | 1998-01-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection |
-
2001
- 2001-05-30 TW TW090113049A patent/TWI270547B/zh not_active IP Right Cessation
- 2001-06-12 BR BR0102377-2A patent/BR0102377A/pt not_active IP Right Cessation
- 2001-06-12 US US09/879,447 patent/US6420359B1/en not_active Expired - Lifetime
- 2001-06-13 UY UY26767A patent/UY26767A1/es not_active Application Discontinuation
- 2001-06-14 CN CNB018112692A patent/CN1178939C/zh not_active Expired - Fee Related
- 2001-06-14 DE DE60118560T patent/DE60118560T2/de not_active Expired - Lifetime
- 2001-06-14 KR KR1020027017173A patent/KR20030017540A/ko not_active Abandoned
- 2001-06-14 AU AU2001270370A patent/AU2001270370B2/en not_active Ceased
- 2001-06-14 HR HR20021003A patent/HRP20021003A2/hr not_active Application Discontinuation
- 2001-06-14 WO PCT/CA2001/000890 patent/WO2001096338A1/en not_active Ceased
- 2001-06-14 PL PL36037001A patent/PL360370A1/xx not_active Application Discontinuation
- 2001-06-14 EA EA200201255A patent/EA005598B1/ru not_active IP Right Cessation
- 2001-06-14 IL IL15281901A patent/IL152819A0/xx unknown
- 2001-06-14 UA UA2003010387A patent/UA74834C2/uk unknown
- 2001-06-14 MX MXPA02012205A patent/MXPA02012205A/es active IP Right Grant
- 2001-06-14 AU AU7037001A patent/AU7037001A/xx active Pending
- 2001-06-14 EP EP01949124A patent/EP1294720B1/en not_active Expired - Lifetime
- 2001-06-14 AT AT01949124T patent/ATE322492T1/de active
- 2001-06-14 PE PE2001000560A patent/PE20020083A1/es not_active Application Discontinuation
- 2001-06-14 SK SK1772-2002A patent/SK17722002A3/sk not_active Application Discontinuation
- 2001-06-14 NZ NZ523549A patent/NZ523549A/en unknown
- 2001-06-14 EE EEP200200690A patent/EE200200690A/xx unknown
- 2001-06-14 JP JP2002510480A patent/JP3923894B2/ja not_active Expired - Lifetime
- 2001-06-14 CA CA002411766A patent/CA2411766C/en not_active Expired - Fee Related
- 2001-06-14 DK DK01949124T patent/DK1294720T3/da active
- 2001-06-14 HU HU0301105A patent/HUP0301105A2/hu unknown
- 2001-06-14 PT PT01949124T patent/PT1294720E/pt unknown
- 2001-06-14 ES ES01949124T patent/ES2261433T3/es not_active Expired - Lifetime
- 2001-06-14 YU YU94202A patent/YU94202A/sh unknown
- 2001-06-14 CZ CZ20024114A patent/CZ20024114A3/cs unknown
- 2001-06-15 AR ARP010102870A patent/AR028958A1/es unknown
- 2001-06-15 MY MYPI20012820A patent/MY130375A/en unknown
- 2001-07-07 SA SA01220202A patent/SA01220202B1/ar unknown
-
2002
- 2002-12-03 BG BG107348A patent/BG107348A/bg unknown
- 2002-12-03 ZA ZA200209807A patent/ZA200209807B/en unknown
- 2002-12-05 NO NO20025844A patent/NO323830B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020083A1 (es) | DERIVADOS DE DIPIRIDO[[3,2-b:2',3'-e][1,4] DIAZEPIN-6-ONA COMO INHIBIDORES DE LA TRANSCRIPTASA INVERSA | |
| PE20011001A1 (es) | Compuestos heterociclicos como inhibidores del intercambio de sodio/protones | |
| PE20030702A1 (es) | Inhibidores de pde9 para tratamiento de transtornos cardiovasculares | |
| AR033344A1 (es) | Compuestos derivados de benzofenonas como inhibidores de la transcriptasa inversa, su uso en la fabricacion de medicamentos, intermediarios y composiciones farmaceuticas | |
| PE20021056A1 (es) | Derivados de pirazol | |
| AR040031A1 (es) | Compuestos de pirazol-pirimidina anilina utiles como inhibidores de cinasa y composiciones farmaceuticas que los contienen | |
| AR027518A1 (es) | Inhibidores de girasas y usos de los mismos | |
| AR020551A2 (es) | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos. | |
| AR043367A2 (es) | Derivados de benzofenona, composiciones farmaceuticas y procesos de preparacion. | |
| CO5320600A1 (es) | Agentes antibacterianos de 3-aminoquinazolin-2,4-dionas | |
| PE20020508A1 (es) | DERIVADOS DE PIRIDINA COMO INHIBIDORES DE LA ACTIVIDAD DE LA QUINASA IkB ß | |
| EP1243582A4 (en) | QUINOLINE, QUINAZOLINE DERIVATIVES, AND MEDICINES CONTAINING SUCH SUBSTANCES | |
| AR019790A2 (es) | Compuestos derivados de la eritromicina, composiciones que los contienen. uso para preparar un medicamento | |
| PE20040071A1 (es) | Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
| PE20020823A1 (es) | Derivados de nucleosidos como inhibidores de polimerasa de arn viral dependiente de arn | |
| PE20200665A1 (es) | Compuestos espirociclicos y sus metodos de preparacion y uso | |
| AR021087A1 (es) | Pirimidin-4-iliden-alquilamina 2,3-sustituida 5,6-anillada, composicion para controlar y prevenir plagas, uso de dichos compuestos para proteger a lasplantas contra la infestacion por microorganismos fitopatogenicos, metodo para controlar o prevenir la infestacion de plantas cultivadas por microorga | |
| KR880005093A (ko) | 5-알킬벤즈이미다졸, 그의 제조방법 및 이들을 함유하는 약제학적 조성물 | |
| PE20040472A1 (es) | Composiciones inhibidoras de la arn polimerasa dependiente de arn del virus de la hepatitis c | |
| PE20220252A1 (es) | Compuestos de pirrol | |
| CO4940477A1 (es) | Inhibidores de proteasa | |
| AR005916A1 (es) | Compuestos de oxadiazol, y de tiadiazol, su uso, procedimientos para prepararlos, composiciones farmaceuticas que los contienen y un compuesto util como intermedio | |
| AR037770A1 (es) | Compuesto inhibidor de la integrasa del vih, composicion farmaceutica que lo comprende y uso del mismo para prepararla | |
| PE20050587A1 (es) | Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales | |
| AR029005A1 (es) | FORMULACION LíQUIDA ESTABLE SIN AGUA O CASI SIN AGUA DE BENCIMIDAZOLES SUSTITUIDOS, PROCESO PARA SU PREPARACIoN, USO DE ESTA FORMULACIoN, Y USO DE POLIETILENGLICOL Y UNA SAL DE SODIO O POTASIO DE UN INHIBIDOR DE H+, K+-ATP ASA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |